Bicycle Therapeutics (BCYC) Asset Utilization Ratio (2019 - 2026)
Bicycle Therapeutics (BCYC) posted Asset Utilization Ratio of 0.09 for Q1 2026, down 5.4% on a QoQ basis from 0.1 in Q4 2025, and up 231.68% year-over-year from 0.03 in Q1 2025.
Bicycle Therapeutics (BCYC) Asset Utilization Ratio (2019 - 2026) Analysis & Trends
Bicycle Therapeutics' Asset Utilization Ratio history runs 8 years deep, the most recent figure standing at 0.09 for Q1 2026.
- Quarterly Asset Utilization Ratio rose 231.68% year-over-year to 0.09 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.09 (up 231.68% YoY) and the FY2025 annual result came in at 0.09, up 90.75% from the prior year.
- Asset Utilization Ratio was 0.09 for Q1 2026 at Bicycle Therapeutics, down from 0.1 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.1 in Q4 2025 and bottomed at 0.02 in Q2 2025.
- A 5-year average of 0.05 and a median of 0.04 in 2024 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio sank 57.13% — and 2025, when it jumped 266.09%.
- Bicycle Therapeutics' Asset Utilization Ratio stood at 0.05 in 2022, then declined by 12.16% to 0.04 in 2023, then plunged by 38.78% to 0.03 in 2024, then soared by 266.09% to 0.1 in 2025, then dropped by 5.4% to 0.09 in 2026.
- Business Quant data shows BCYC's Asset Utilization Ratio at 0.09 in Q1 2026, 0.1 in Q4 2025, and 0.04 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Bicycle Therapeutics | 289.88 Mn | 289.88 Mn | - | 0.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.09 |
| Dec 31, 2025 | 0.10 |
| Sep 30, 2025 | 0.04 |
| Jun 30, 2025 | 0.02 |
| Mar 31, 2025 | 0.03 |
| Dec 31, 2024 | 0.03 |
| Sep 30, 2024 | 0.03 |
| Jun 30, 2024 | 0.04 |
| Mar 31, 2024 | 0.06 |
| Dec 31, 2023 | 0.04 |
| Sep 30, 2023 | 0.05 |
| Jun 30, 2023 | 0.06 |
| Mar 31, 2023 | 0.05 |
| Dec 31, 2022 | 0.05 |
| Sep 30, 2022 | 0.03 |
| Jun 30, 2022 | 0.03 |
| Mar 31, 2022 | 0.02 |
| Dec 31, 2021 | 0.03 |
| Sep 30, 2021 | 0.05 |
| Jun 30, 2021 | 0.05 |